Pharmacoepidemiology and Drug Safety

© John Wiley & Sons, Ltd.

Cover image for Pharmacoepidemiology and Drug Safety

January 2008

Volume 17, Issue 1

Pages 1–105, i–xii

  1. Original Reports

    1. Top of page
    2. Original Reports
    3. Letters to the Editor
    4. Errata
    5. Current Awareness
    1. Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods (pages 1–8)

      Edwin P. Martens, Anthonius de Boer, Wiebe R. Pestman, Svetlana V. Belitser, Bruno H. Ch. Stricker and Olaf H. Klungel

      Article first published online: 24 OCT 2007 | DOI: 10.1002/pds.1520

    2. Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal (pages 9–19)

      Myrthe P. P. Sukel, Michiel W. van der Linden, Connie Chen, Joëlle A. Erkens and Ron M. C. Herings

      Article first published online: 25 OCT 2007 | DOI: 10.1002/pds.1508

    3. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data (pages 20–26)

      Christianne L. Roumie, Edward Mitchel, Patricia S. Gideon, Cristina Varas-Lorenzo, Jordi Castellsague and Marie R. Griffin

      Article first published online: 2 NOV 2007 | DOI: 10.1002/pds.1518

    4. Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients (pages 27–36)

      Gary D. Friedman, E. Dawn Flick, Natalia Udaltsova, James Chan Pharm D, Charles P. Quesenberry Jr. and Laurel A. Habel

      Article first published online: 18 OCT 2007 | DOI: 10.1002/pds.1507

    5. Prevalence of purchase of antihypertensive and serum lipid-reducing drugs in Sweden—individual data from national registers (pages 37–42)

      Louise Silwer, Cecilia Stålsby Lundborg and Max Petzold

      Article first published online: 6 NOV 2007 | DOI: 10.1002/pds.1515

    6. Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population (pages 43–51)

      George A. Makar, Mark G. Weiner, Stephen E. Kimmel, Dimitri Bennett, Anne Burke, Yu-Xiao Yang, Xiaoyan Han, Kimberly Sellers, Lisa Nessel and James D. Lewis

      Article first published online: 26 OCT 2007 | DOI: 10.1002/pds.1514

    7. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy—a descriptive study (pages 52–61)

      Fokaline Vroom, Eric N. van Roon, Paul B. van den Berg, Jacobus R.B.J. Brouwers and Lolkje T.W. de Jong-van den Berg

      Article first published online: 19 OCT 2007 | DOI: 10.1002/pds.1506

    8. Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997–2003 (pages 62–69)

      Chi-Wen Chiang, Hui-Fen Chiu, Chi-Yu Chen, Hsin-Lung Wu and Chun-Yuh Yang

      Article first published online: 9 OCT 2007 | DOI: 10.1002/pds.1513

    9. Effect of concomitant treatment with a CYP3A4 inhibitor and a calcium channel blocker (pages 70–75)

      Masanori Yoshida, Takuyuki Matsumoto, Tatsuo Suzuki, Shigeto Kitamura and Takashi Mayama

      Article first published online: 4 OCT 2007 | DOI: 10.1002/pds.1480

    10. Expectations of general practitioners and specialist doctors regarding the feedback received after reporting an adverse drug reaction (pages 76–81)

      Lotte Cornelissen, Eugène van Puijenbroek and Kees van Grootheest

      Article first published online: 6 NOV 2007 | DOI: 10.1002/pds.1516

    11. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia (pages 82–89)

      Chong Chee Ping, Mohd Baidi Bahari and Mohamed Azmi Hassali

      Article first published online: 19 SEP 2007 | DOI: 10.1002/pds.1477

    12. Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database) (pages 90–102)

      Lia P. Gutiérrez, Maria Kołtowska-Häggström, Peter J. Jönsson, Anders F. Mattsson, Dag Svensson, Björn Westberg and Anton Luger

      Article first published online: 24 OCT 2007 | DOI: 10.1002/pds.1510

  2. Letters to the Editor

    1. Top of page
    2. Original Reports
    3. Letters to the Editor
    4. Errata
    5. Current Awareness
    1. Response to: validation studies of the health improvement network (THIN) database for pharmacoepidemiology research by Lewis et al. (pages 103–104)

      T. P. van Staa and J. Parkinson

      Article first published online: 18 DEC 2007 | DOI: 10.1002/pds.1525

    2. Response to van Staa and Parkinson (page 104)

      James D. Lewis, Rita Schinnar, Warren B. Bilker, Xingmei Wang and Brian L. Strom

      Article first published online: 18 DEC 2007 | DOI: 10.1002/pds.1523

  3. Errata

    1. Top of page
    2. Original Reports
    3. Letters to the Editor
    4. Errata
    5. Current Awareness
    1. You have free access to this content
      Erratum: Hepatitis B vaccination and multiple sclerosis: a data mining perspective (page 105)

      Manfred Hauben, Motonobu Sakaguchi, Vaishali Patadia and Charles M Gerrits

      Article first published online: 18 DEC 2007 | DOI: 10.1002/pds.1524

  4. Current Awareness

    1. Top of page
    2. Original Reports
    3. Letters to the Editor
    4. Errata
    5. Current Awareness
    1. Current awareness: Pharmacoepidemiology and drug safety (pages i–xii)

      Article first published online: 18 DEC 2007 | DOI: 10.1002/pds.1482

SEARCH

SEARCH BY CITATION